Irreversible left atrium dilatation preceding left ventricular dysfunction during trastuzumab therapy

Minerva Cardioangiol. 2018 Apr;66(2):223-224. doi: 10.23736/S0026-4725.17.04483-8.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Agents, Immunological / administration & dosage
  • Antineoplastic Agents, Immunological / adverse effects*
  • Breast Neoplasms / drug therapy
  • Dilatation, Pathologic / chemically induced
  • Female
  • Heart Atria / physiopathology*
  • Humans
  • Middle Aged
  • Trastuzumab / administration & dosage
  • Trastuzumab / adverse effects*
  • Ventricular Dysfunction, Left / chemically induced*

Substances

  • Antineoplastic Agents, Immunological
  • Trastuzumab